LEP and diabetes mellitus: Many different models have been used to address mechanisms for how obesity and metabolic disease causes cardiac remodeling and HF development, including leptin or leptin receptor deficient mice and mice with pharmacologically induced (e.g., streptozotocin) diabetes (32).